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SUMMARY – Th yroid-associated orbitopathy (TAO) is a common manifestation of Graves’ dis-
ease. Th e aim of the study was to assess the six percent of patients with TAO that develop dysthyroid 
optic neuropathy (DON), which is the most serious complication of TAO. As DON can cause per-
manent damage, it is essential to detect DON early when visual loss is still reversible. Color Doppler 
ultrasound is a noninvasive diagnostic method, which may be useful in early detection of DON. 
Th irty-six patients with confi rmed Graves’ disease and active TAO were included, 21 (58%) of them 
with early DON (eDON) and 15 (42%) free from any signs of eDON. All study patients underwent 
Doppler ultrasound examination to determine the blood fl ow rates in the internal carotid artery, oph-
thalmic artery, and central retinal artery. Study results showed color Doppler ultrasound examination 
to have a potential to detect orbital blood fl ow changes in patients with eDON. Early detection of 
DON may result in earlier treatment and prevention of permanent optic nerve damage.
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Introduction
Th yroid-associated orbitopathy (TAO) is a com-
mon manifestation of Graves’ disease. TAO may be 
caused by high levels of circulating thyroid-stimulat-
ing immunoglobulins, T-cell activation and orbital fi -
broblast activation, and it is characterized by edema 
and infi ltration of extraocular muscles and other or-
bital tissues1,2.
Six percent of patients with TAO develop dysthy-
roid optic neuropathy (DON); compression of the op-
tic nerve by enlarged orbital tissues in the orbital apex 
likely accounts for the majority of these cases3. DON 
is the most serious complication of TAO because it can 
cause permanent visual impairment and blindness in 
30% of aff ected patients4. As DON can cause perma-
nent damage, it is essential to detect DON as early as 
possible, when visual loss is still reversible and when 
appropriate therapy may result in full or substantial re-
covery of visual function5.
Unfortunately, DON is very diffi  cult to diagnose in 
a timely fashion because its signs and symptoms (de-
creased visual acuity, relative aff erent pupillary defect, 
edema of the optic nerve head, visual fi eld defects, and 
color vision impairment) are often subtle and can 
therefore be missed if they are not screened for spe-
cifi cally1,6. Clinical assessment of DON should deter-
mine the occurrence of symptoms such as blurring, 
color desaturation, or the appearance of grey spots, 
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testing of visual acuity, color discrimination and rela-
tive pupillary defect, and should include funduscopy to 
determine disc appearance and the presence of choroi-
dal folds. Optional investigations include perimetry, 
contrast sensitivity testing, electrodiagnostic tests, and 
imaging to look for apical crowding6. Currently, there 
is no standard criterion to base the diagnosis, especial-
ly in cases of early DON (eDON).
Patients with DON and visual acuity measuring 
under 0.7 have never regained normal visual acuity 
(1.0), and other clinical parameters have not normal-
ized after treatment7. Th is suggests that the impair-
ment of optic nerve function occurs before the appear-
ance of the fi rst clinical signs8.
Visual acuities of 0.5 or better are present in 50%-
70% of eyes with DON9. In addition, there is clear 
evidence that DON can be present even with normal 
vision10. In some patients, visual acuity of 1.0 may al-
ready represent reduction in their normal visual acuity, 
whereas in other patients, visual acuity is still unaf-
fected at the time DON is diagnosed.
A number of noninvasive diagnostic methods for 
detecting eDON have shown some potential, such as 
visual evoked potentials (VEP), contrast sensitivity 
testing, and perimetry10. Color Doppler ultrasound is 
another noninvasive diagnostic method that off ers 
quantitative analysis of blood fl ow; it can detect small 
subclinical changes in fl ow rates even in vessels with 
very low blood fl ow, such as orbital vessels. To our 
knowledge, only two reports on color Doppler ultra-
sound of orbital vasculature in patients with Graves’ 
disease have been published11,12. Th erefore, this study 
aimed to investigate diagnostic potential of color Dop-
pler ultrasound of orbital vessels in detecting eDON. 
We used color Doppler to measure orbital circulation 
parameters and to examine the primary hypothesis 
that eDON is associated with signifi cant changes in 
orbital blood fl ow.
Patients and Methods
Th is was a cohort study that included 36 patients 
with confi rmed Graves’ disease, from the Endocrinol-
ogy Department, Split University Hospital Center, 
Split, Croatia. Study patients were divided into two 
groups according to contrast sensitivity testing and 
static perimetry results. Th e fi rst group of 21 (58%) pa-
tients had eDON (patients with eDON had patho-
logic contrast sensitivity and static perimetry test re-
sults), while second group of 15 (42%) patients had no 
signs of DON (normal contrast sensitivity and static 
perimetry results). We enrolled both men and women 
aged 35 to 60 years. All patients had previously been 
diagnosed with Graves’ disease, had best corrected vi-
sual acuity (BCVA) ≥0.7 (Snellen chart), enlarged ex-
traocular muscles on multi-slice computed tomogra-
phy (MSCT) scans, and active TAO confi rmed by a 
clinical activity score ≥413. We excluded all patients 
with congenital or pathologic color vision disturbanc-
es, relative aff erent pupillary defects, edematous or pale 
optic nerve heads, as well as patients with glaucoma, 
ocular hypertension, patients with ocular surface dis-
eases, previous eye or orbital surgeries and other dis-
eases of the eye, optic nerve or orbit. Th e research was 
performed at the Ophthalmology, Neurology, and Ra-
diology Departments, Split University Hospital Cen-
ter, Split, Croatia.
Th e following examinations were performed in all 
study patients: central visual acuity testing (Snellen 
charts); contrast sensitivity testing (CST) with Gins-
burg’s test CST-1800 (Vision Sciences Research Cor-
poration, San Ramon, USA); indirect dilated ophthal-
moscopy; intraocular pressure measurement with 
Goldmann’s applanation tonometry; Hertell’s exoph-
thalmometry; static perimetry (Standard Examination 
Programs/normal examination with 76 locations) on 
the Octopus 101 (Haag Streit USA, Mason, OH, 
USA); color Doppler examination of the blood fl ow 
rate in the internal carotid artery (ICA), ophthalmic 
artery (OA), and central retinal artery (CRA) using 
SONO ACE 6000 C ultrasound (Medison Austria, 
South Korea) and a 7.5 MHz linear probe; and MSCT 
scans of the orbit to determine the volume change in 
extraocular muscles and orbital fatty tissue.
We considered the patient to have eDON if the 
mean defect value of the visual fi eld testing was higher 
than 4 (normal values from -2 to 2) and CST curve 
passed beneath 5.5 cycles per degree (C/D) for low and 
medium frequencies and beneath 2.0 C/D for high 
frequencies on three occasions.
Data were expressed as mean ± standard deviation 
for continuous variables and percentages for categori-
cal variables. For distribution evaluation, we used de-
scriptive statistics methods, and normal data distribu-
tion was verifi ed by Kolomogorov-Smirnov test. We 
used χ2-test to determine the association between gen-
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der and eDON. Diff erence in blood fl ow parameters 
and age between the two groups of patients was tested 
by Mann-Whitney U test or two-tailed Student’s t-
test for unmatched samples, depending on the charac-
teristics of distribution. Th e receiver operating charac-
teristic curve (ROC) and logistic regression were used 
in the analysis of prognostic values of individual pa-
rameters for eDON (blood fl ow, age, contrast sensitiv-
ity and visual fi elds). Spearman coeffi  cient of correla-
tion was used on bivariate correlation analysis of fl ow 
parameters and contrast sensitivity test results. In all 
tests, we set the level of signifi cance at α=0.05. All sta-
tistical analyses were performed using the SPSS, ver-
sion 13 (SPSS, Inc., Chicago, IL, USA) software.
Results
In this study, 36 patients were enrolled, 21 (58%) of 
them diagnosed with eDON. All patients were aged 
between 36 and 57 years (mean ± SD=50.16±6.43). 
Th ere were eight (22%) male and 28 (78%) female pa-
tients. Despite the large number of female patients in 
both groups, no diff erences related to age distribution 
and sex were found (χ2=4.876; df=1; p=0.003).
Th ere were no signifi cant between-group diff er-
ences in Doppler ultrasound parameters for the ICA, 
although the pulsatility index showed higher mean 
values with borderline signifi cance in the group with-
out eDON (Table 1). However, when compared with 
eDON patients, the group without eDON had sig-
nifi cantly higher Doppler ultrasound parameters for 
the OA (peak systolic fl ow velocity p=0.019, mean 
fl ow p=0.013) and for the CRA (peak systolic fl ow ve-
locity p=0.010, end diastolic fl ow velocity p<0.001, re-
sistivity index p=0.009).
We also tested for correlation between all Doppler 
ultrasound parameters with contrast sensitivity results 
or with visual fi eld results (Table 2). For the ICA, we 
found a strong positive correlation between the peak 
systolic fl ow velocity and contrast sensitivity test re-
sults (r=0.54; p=0.001), as well as between the mean 
fl ow and contrast sensitivity test results (r=0.37; 
p=0.027). Th ere was no signifi cant correlation with vi-
sual fi eld results. For the OA, we found a signifi cant 
negative correlation between the contrast sensitivity 
results and peak systolic fl ow velocity (r=-0.35; p=
0.038), end diastolic fl ow velocity (r=-0.44; p=0.008), 
and mean fl ow (r=-0.43; p=0.009). Additionally, there 
Table 1. Doppler ultrasound parameter mean values for examined arteries in patients with and without early 











SFV 360.74±55.87 352.06±88.00 -0.33 0.74
DFV 100.83±41.39 112.21±26.60 1.00 0.32
VMEAN 230.78±42.39 232.17±54.02 0.08 0.93
RI 0.68±0.06 0.72±0.10 1.82 0.07
PI 1.03±0.13 1.15±0.24 1.99 0.05
OA
SFV 328.86±80.31 396.96±81.61 2.48 0.01
DFV 68.70±28.15 89.12±34.24 1.89 0.06
VMEAN 198.76±50.68 247.74±57.13 2.65 0.01
RI 0.78±0.06 0.79±0.06 0.64 0.52
PI 1.26±0.17 1.32±0.16 0.98 0.33
CRA
SFV 235.82±58.04 300.39±74.91 2.79 0.01
DFV 44.11±18.52 70.29±21.61 3.80 <0.001
VMEAN 139.97±36.10 170.38±58.72 1.78 0.08
RI 0.76±0.05 0.82±0.06 2.69 0.009
PI 1.94±2.66 1.38±0.17 -0.80 0.43
ICA = internal carotid artery; OA = ophthalmic artery; CRA = central retinal artery; SFV = peak systolic fl ow velocity; DFV = end  diastolic 
fl ow velocity; VMEAN = mean fl ow; RI = resistivity index; PI = pulsatility index; †t-Student’s t-test
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was a borderline positive correlation between pulsatil-
ity index and contrast sensitivity (r=0.33; p=0.046). 
For the OA, a negative correlation was found between 
the visual fi eld results and peak systolic fl ow velocity 
(r=-034; p=0.04) and mean fl ow (r=-0.39; p=0.018). 
For the CRA, we found a signifi cant negative correla-
tion between the contrast sensitivity results and peak 
systolic fl ow velocity (r=-0.36; p=0.03) and end dia-
stolic fl ow velocity (r=-0.55; p<0.001). In the CRA, 
there was a signifi cant positive correlation between the 
resistance index and contrast sensitivity (r=0.5; 
p=0.002), as well as positive correlation between the 
visual fi eld results and peak systolic (r=0.023; p=0.023) 
and diastolic fl ow velocity (r=0.023; p=0.023).
We performed ROC analysis to examine the 
screening sensitivity and specifi city of Doppler ultra-
sound of the ICA, OA and CRA for detection of 
eDON. Th e results for each individual fl ow parameter 
used as a predictor of eDON are shown for all arteries.
According to ROC analysis, the CRA demonstrat-
ed the highest predictive potential for eDON, whereas 
the other two arteries are weak predictors. Neverthe-
less, only the peak systolic fl ow velocity of the ICA 
showed visible deviation from the reference line. Th e 
infl ection point of ROC curve indicated the area with 
satisfactory sensitivity and specifi city (70% sensitivity 
and 66% specifi city).
Discussion
Th e present study found the orbital blood fl ow pa-
rameters to be signifi cantly lower in patients with 
eDON than in those without eDON. According to 
our literature search, this is the fi rst report on this sub-
ject. Kurioka et al. and Alp et al. have previously re-
ported a signifi cant diff erence in the fl ow rates in pa-
tients with TAO when compared to the fl ow rates of 
the general population14,15. Th ey also found a signifi -
cant correlation between the resistivity index and Bar-
rett’s muscle index (an index that quantifi es extraocu-
lar muscle impingement on the optic nerve)14-16.
In this study, we examined the diff erence in orbital 
blood fl ow parameters between the patients with 
eDON and patients with active TAO that did not have 
signs of optic nerve damage. It is known that orbital 
blood fl ow may change secondary to the pathologic 
sequels of hyperthyroidism, which include increased 
systemic blood pressure, increased intraocular pressure, 
and orbital infl ammation.
We found that the resistivity index, peak systolic 
fl ow velocity and end diastolic fl ow velocity for the 
CRA were signifi cantly lower in the group of patients 
with eDON as compared with the control group with-
out eDON. Th ese fi ndings could be explained by blood 
fl ow autoregulation mechanisms. In the group without 
Table 2. Correlations between fl ow parameters for ophthalmic artery and central retinal 
artery, contrast sensitivity, and visual fi eld parameters
Flow parameters vs. 
contrast sensitivity












SFV -0.35 0.03 -0.34 0.04
DFV -0.44 0.008 -0.26 0.13
VMEAN -0.43 0.009 -0.39 0.01
RI 0.28 0.09 0.20 0.23
PI 0.33 0.04 0.25 0.13
CRA
SFV -0.36 0.030 0.02 0.02
DFV -0.55 <0.001 0.02 0.02
VMEAN -0.23 0.18 0.12 0.12
RI 0.50 0.002 0.22 0.19
PI 0.31 0.06 0.09 0.59
OA = ophthalmic artery; CRA = central retinal artery; SFV = peak systolic fl ow velocity; DFV = end  diastolic 
fl ow velocity; VMEAN = mean fl ow; RI = resistivity index; PI = pulsatility index; †Spearman coeffi  cient of 
correlation
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eDON, a higher resistance in the CRA leads to higher 
fl ow rates. In patients with eDON, the decrease of 
blood fl ow is likely due to infl ammatory damage in the 
orbital tissues. Th ese changes in orbital blood fl ow may 
ultimately cause hypoxia and optic nerve damage.
We also found a positive correlation between the 
contrast sensitivity test results and the resistivity index 
for CRA, and between the visual fi eld results and peak 
systolic and end diastolic fl ow velocities for CRA. Th ese 
results, although surprising, show that in the early stage 
of DON, orbital blood fl ow exhibits great hemodynam-
ic instability and damage to the optic nerve is still suf-
fi cient to cause clinically signifi cant functional damage. 
Th erefore, if we detect DON in its early stage and treat 
it appropriately, we could prevent permanent optic 
nerve damage. However, if DON is left untreated and 
reaches late stage, then irreversible damage to the optic 
nerve develops due to long-lasting hypoxia, which leads 
to permanent visual fi eld defects and loss of visual acu-
ity. In cases of recurrence, in older patients and in smok-
ers, functional recovery of the optic nerve after DON is 
less probable, which confi rms that hypoxia, as well as 
infl ammation may be the principal pathogenic cause of 
permanent optic nerve damage.
Our ROC analysis showed that CRA fl ow had the 
highest predictive potential for detecting eDON, sug-
gesting that the posterior ciliary arteries may also have 
a high predictive potential for detecting eDON. Fu-
ture investigations could explore blood fl ow in the 
posterior ciliary arteries with more sensitive 10 MHz 
ultrasound probes.
Th e advantage of color Doppler ultrasound exami-
nation of the orbital blood fl ow in detection of eDON 
is that it is not biased by patient compliance (com-
pared to visual fi eld and CST) and may be used even 
in patients not cooperative enough for cognitive visual 
tests.
It is known that patients with late DON have a 
higher resistivity index and higher velocity blood fl ow 
velocity in orbital vessels when compared with the 
general population15,16. We found that color Doppler 
ultrasound examination could detect orbital blood 
fl ow changes in these patients, with early cases of 
DON demonstrating lower velocity orbital blood 
fl ows, probably mostly due to orbital infl ammation. It 
remains unknown whether irreversible damage to the 
optic nerve occurs at a specifi c blood fl ow cutoff 
point16. Additional studies may identify whether a 
quantifi able decrease in blood fl ow is associated with 
damage, as well as elucidate whether other factors con-
tribute to nerve damage, such as infl ammation, chang-
es in orbital blood fl ow autoregulatory mechanisms, 
and genetically determined susceptibility of optic 
nerve fi bers. Future studies should also examine the 
eff ect of corticosteroid therapy in patients with eDON 
to determine its use as a possible treatment to prevent 
irreversible optic nerve damage.
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Sažetak
POREMEĆAJI CIRKULACIJE U KRVNIM ŽILAMA ORBITE 
DIJAGNOSTICIRANI OBOJENIM DOPPLEROVIM ULTRAZVUKOM 
KOD BOLESNIKA S RANIM STADIJEM DISTIROIDNE OPTIČKE NEUROPATIJE
M. Lešin, V. Rogošić, L. Vanjaka Rogošić, I. Barišić i G. Pelčić
Problemi štitnjače i povezane orbitopatije (TAO) najčešća su manifestacija Gravesove bolesti. Cilj ove studije bio je 
objasniti 6% bolesnika s TAO kod kojih se razvila distiroidna optička neuropatija (DON), koja je ujedno najozbiljnija 
 komplikacija TAO. S obzirom na to da DON može izazvati trajno oštećenje vida, vrlo ga je važno rano prepoznati dok je 
vidna funkcija još očuvana i reverzibilna. Obojeni Dopplerov ultrazvuk je neinvanzivna dijagnostička metoda koja je vrlo 
djelotvorna u ranom otkrivanju DON-a. U studiju je bilo uključeno 36 bolesnika s dijagnosticiranom Gravesovom bolesti i 
TAO-om, od kojih je 21 (58%) bolesnik imao rani DON (early DON, eDON), dok 15 (42%) bolesnika nije imalo znakova 
eDON-a. Svakom ispitaniku učinjen je obojeni Dopplerov ultrazvuk kako bi se odredio stupanj protoka krvi (cirkulacije) u 
unutarnjoj karotidnoj arteriji, oftalmičkoj arteriji i središnjoj retinalnoj arteriji. Rezultati su pokazali da pregled obojenim 
Dopplerovim ultrazvukom ima visok potencijal u ranoj dijagnostici promjena cirkulacije u orbiti kod bolesnika s ranim 
eDON-om. Rano otkrivanje DON-a može pomoći u ranijem liječenju i prevenciji trajnog oštećenja vidnoga živca.
Ključne riječi: Gravesova oftalmopatija; Gravesova bolest; vidni živac, bolesti; ultrazvučno snimanje, kolor dopler; vidni živac, 
ozljede
